Medical Director Appointed to Hospice of Charleston's In Home Hospice Care
Charleston, SC --- Hospice of Charleston-a Gentiva company announced the appointment of Dr. Tresha T. Ward as medical director of their hospice home care division, serving patients and families in Berkeley, Dorchester, and Charleston counties.
Dr. Ward, a Board Certified Family Practice Physician, graduated from the University of Maryland in Baltimore and completed her Family Practice residency there also. Dr. Ward currently works part time as an independent hospitalist for Roper St. Francis Hospital.
Prior to this appointment, Dr. Ward was a Family Physician with CareSouth Carolina, Hartsville, SC. Her position involved both inpatient/outpatient work. Her greatest accomplishment while there was building the practice to capacity faster than any physician in the 20 year history of the 11 site community health center. She has an extensive background in pain management and the treatment of opioid dependency.
Born in Washington D.C., Dr. Ward relocated to South Carolina to complete her Public Health Service commitment and loves Charleston. She and her husband, Tom and have been married for 32 years and are the parents of 3 adult children. They have 2 grandchildren and another on the way! She enjoys their 6 dogs, gardening and crocheting.
Hospice of Charleston provides in home hospice care to patients and families throughout Greater Charleston. Hospice of Charleston in home hospice is also under the medical direction of Dr. William Wilson. Hospice of Charleston also has an inpatient facility that provides disease management to terminally ill patients. Dr. Angus Baker and Dr. R. Scott Lake are the Medical Directors of the 20 bed in-patient facility of Hospice of Charleston.
Forward-Looking Statement
Certain statements contained in this news release, including, without limitation, statements containing the words “believes,” “anticipates,” “intends,” “expects,” “assumes,” “trends” and similar expressions, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company’s current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: the Company’s ability to successfully integrate the operations of The Healthfield Group, Inc., and to achieve expected synergies and operating efficiencies within expected time frames or at all; the possibility that revenues may be lower than expected following the transaction; the possibility that difficulties in maintaining relationships with employees, customers, or suppliers may be greater than expected following the transaction; the Company’s ability to service debt incurred as a result of the transaction; general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company’s various filing with the Securities and Exchange Commission (SEC), including the “Risk Factors” section contained in the Company’s annual report on Form 10-K for the year ended January 1, 2006.
# # #
